Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis

Maspero, JF; Katelaris, CH; Busse, WW; Castro, M; Corren, J; Chipps, BE; Peters, AT; Pavord, ID; Ford, LB; Sher, L; Rabe, KF; Rice, MS; Rowe, P; Lu, YF; Harel, S; Jagerschmidt, A; Khan, AH; Kamat, S; Pirozzi, G; Amin, N; Ruddy, M; Graham, NMH; Mannent, LP; Teper, A

Maspero, JF (corresponding author), Fdn CIDEA, Paraguay 2035,C1121ABE, Buenos Aires, DF, Argentina.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020; 8 (2): 527

Abstract

BACKGROUND: Dupilumab, a fully human monoclonal antibody, blocks the shared receptor component for IL-4 and IL-13 signaling, key drivers of type 2 inf......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索